OA02.05 Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study

Yi‐Long Wu, Q. Zhou, Mengkai Chen, Yiru Pan, O. Jian, Deao Hu, Q. Lin, Guan-You Wu, J. Cui, J. Chang, Y. Cheng, Chenguang Huang, A. Liu, Nuan Yang, Y. Gong, CHANG-QING ZHU, Zheng Ma, J. Fang, G. Chen, Junkai Zhao, Anwei Shi, Y. Lin, G. Li, Y. Liu, D. Wang, R. Wu, Xingnong Xu, J. Shi, Z. Liu, J. Wang, J. Yang